1. Search Result
Search Result
Results for "

lysyl

" in MedChemExpress (MCE) Product Catalog:

48

Inhibitors & Agonists

1

Fluorescent Dyes

2

Biochemical Assay Reagents

8

Peptides

2

Inhibitory Antibodies

3

Natural
Products

8

Recombinant Proteins

8

Antibodies

2

Oligonucleotides

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-Y1750
    β-Aminopropionitrile
    10+ Cited Publications

    BAPN

    Monoamine Oxidase Endogenous Metabolite Metabolic Disease Cancer
    β-Aminopropionitrile (BAPN) is a specific, irreversible and orally active lysyl oxidase (LOX) inhibitor. β-Aminopropionitrile targets the active site of LOX or LOXL isoenzymes .
    β-Aminopropionitrile
  • HY-138625A
    PXS-5505 anhydrous
    2 Publications Verification

    LOX-IN-3 dihydrochloride

    Monoamine Oxidase Cancer
    PXS-5505 anhydrous (LOX-IN-3 dihydrochloride) is an orally active lysyl oxidase (LOX) inhibitor. PXS-5505 anhydrous can be used for fibrosis, cancer and angiogenesis research .
    PXS-5505 anhydrous
  • HY-138625
    PXS-5505 free base
    2 Publications Verification

    LOX-IN-3

    Monoamine Oxidase Cancer
    PXS-5505 free base (LOX-IN-3) is an orally active lysyl oxidase (LOX) inhibitor. PXS-5505 free base can be used for fibrosis, cancer and angiogenesis research .
    PXS-5505 free base
  • HY-107422
    Lenumlostat
    3 Publications Verification

    PAT-1251; GB2064

    Monoamine Oxidase Inflammation/Immunology
    PAT-1251 is a potent, selective and oral lysyl oxidase-like 2 (LOXL2) inhibitor, with IC50s of 0.71 and 1.17 μM for hLOXL2 and hLOXL3, respectively, and also potently inhibits mouse, rat, and dog LOXL2 (IC50s, 0.10, 0.12, and 0.16 μM, respectively); PAT-1251 is used in the research of fibrotic diseases .
    Lenumlostat
  • HY-P3205
    Lysyl endopeptidase, Achromobacter sp
    1 Publications Verification

    Lys-C

    Biochemical Assay Reagents Others
    Lysyl endopeptidase, Achromobacter sp (Lys-C) catalyzes carboxyl oxygen exchange reaction. Lysyl endopeptidase has higher substrate binding affinities and higher catalytic rates at the acidic pHs than at the alkaline pHs .
    Lysyl endopeptidase, Achromobacter sp
  • HY-130242

    Monoamine Oxidase Inflammation/Immunology
    PXS-5120A is a potent, irreversible fluoroallylamine inhibitor of Lysyl Oxidase-like 2/3 (LOXL2/3) with anti-fibrotic activity. PXS-5120A is >300-fold selective for LOXL2 (Ki of 83 nM; pIC50 of 8.4) over LOXL (pIC50 of 5.8) .
    PXS-5120A
  • HY-P99047

    AB 0024; GS 6624

    Monoamine Oxidase Cardiovascular Disease Inflammation/Immunology
    Simtuzumab (AB 0024; GS 6624) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2). Simtuzumab non-competitively blocks collagen cross-linking, reduces LOXL2 protein expression and attenuates extracellular matrix changes. Simtuzumab reduces myocardial fibrosis and prevents cardiac dysfunction. Simtuzumab lowers Myh7 and Nppa gene expression, reduces contraction heterogeneity, and cuts COL1A1 deposition. Simtuzumab can be used for the research of LMNA mutation-induced dilated cardiomyopathy, idiopathic pulmonary fibrosis, and primary sclerosing cholangitis .
    Simtuzumab
  • HY-170422

    lysyl-DOPG

    Biochemical Assay Reagents Infection
    18:1 Lysyl PG (Lysyl-DOPG) is a cationic phospholipid contains a lysine group and a DOPG .
    18:1 Lysyl PG
  • HY-126130
    LysRs-IN-2
    1 Publications Verification

    Aminoacyl-tRNA Synthetase Infection
    LysRs-IN-2 is a lysyl-tRNA synthetase (KRS) inhibitor with IC50s of 0.015 μM and 0.13 μM for Plasmodium falciparum lysyl-tRNA synthetase (PfKRS) and Cryptosporidium parvum lysyl-tRNA synthetase (CpKRS), respectively .
    LysRs-IN-2
  • HY-114286A
    PXS-5153A monohydrochloride
    1 Publications Verification

    Monoamine Oxidase Inflammation/Immunology
    PXS-5153A monohydrochloride is a potent, selective, orally active and fast-acting lysyl oxidase like 2/3 enzymatic (LOXL2/LOXL3) inhibitor, with an IC50 of <40 nM for LOXL2 across all mammalian species and an IC50 of 63 nM for human LOXL3. PXS-5153A monohydrochloride could reduce crosslinks and ameliorates fibrosis.
    PXS-5153A monohydrochloride
  • HY-151499A

    Monoamine Oxidase Inflammation/Immunology
    PXS-6302 hydrochloride is an irreversible lysyl oxidase inhibitor with IC50s of 3.7 μM (Bovine LOX), 3.4 μM (rh LOXL1), 0.4 μM (rh LOXL2), 1.5 μM (rh LOXL3), 0.3 μM (rh LOXL4), respectively. PXS-6302 hydrochloride has readily skin penetrability, reduces collagen deposition and significantly improves scar appearance .
    PXS-6302 hydrochloride
  • HY-149597

    Monoamine Oxidase Cancer
    Lysyl hydroxylase 2-IN-1 (compound 12) is a selective lysyl hydroxylase 2 (LH2) Inhibitor with an IC50 of ~300 nM. Lysyl hydroxylase 2-IN-1 demonstrates selectivity for LH2 over LH1 and LH3 .
    Lysyl hydroxylase 2-IN-1
  • HY-114788

    L-lysyl-L-cysteine; Lys-Cys; H-Lys-Cys-OH

    Amino Acid Derivatives Others
    Lysylcysteine (L-Lysyl-L-cysteine) is a dipeptide composed of lysine and cysteine.
    Lysylcysteine
  • HY-170538

    Lysyl Oxidase Cytochrome P450 Cardiovascular Disease Metabolic Disease
    SNT-5382 is a lysyl oxidase family (LOX) inhibitor and anti-fibrotic agent. SNT-5382 binds to the LTQ cofactor of LOXL2 and inhibits the enzymatic activities of LOXL3, LOXL4, LOXL1, CYP2C9, and CYP2C19. SNT-5382 reduces cardiac and liver fibrosis as well as collagen crosslinks, and improves cardiac function. SNT-5382 can be used for the research of heart failure, myocardial infarction, and nonalcoholic steatohepatitis-related liver fibrosis .
    SNT-5382
  • HY-151499

    Monoamine Oxidase Others
    PXS-6302 is an irreversible lysyl oxidase inhibitor with IC50s of 3.7 μM (Bovine LOX), 3.4 μM (rh LOXL1), 0.4 μM (rh LOXL2), 1.5 μM (rh LOXL3), 0.3 μM (rh LOXL4), respectively. PXS-6302 has readily skin penetrability, reduces collagen deposition and significantly improves scar appearance .
    PXS-6302
  • HY-170573A

    Monoamine Oxidase Cancer
    LOX-IN-5 tosylate (compound 22) is a selective and orally active lysyl oxidase-like 2 (LOXL2) inhibitor with an IC50 of <300 nM. LOX-IN-5 tosylate possess anti-fibrosis properties .
    LOXL2-IN-1 tosylate
  • HY-Y1750A

    BAPN hydrochloride

    Monoamine Oxidase Endogenous Metabolite Metabolic Disease Cancer
    β-Aminopropionitrile (BAPN) hydrochloride is a specific, irreversible and orally active lysyl oxidase (LOX) inhibitor. β-Aminopropionitrile hydrochloride targets the active site of LOX or LOXL isoenzymes .
    β-Aminopropionitrile hydrochloride
  • HY-103280

    Aminoacyl-tRNA Synthetase Others
    LysRs-IN-1 is a Lysyl-tRNA synthetase (LysRs) inhibitor.
    LysRs-IN-1
  • HY-151498A

    Monoamine Oxidase Others
    PXS-4787 hydrochloride is a specific and effective pan-LOX (lysyl oxidase) inhibitor for abolishing lysyl oxidase activity. PXS-4787 hydrochloride inhibits LOX with IC50s of 2 μM (Bovine LOX), 3.2 μM (rh LOXL1), 0.6 μM (rh LOXL2), 1.4 μM (rh LOXL3), 0.2 μM (rh LOXL4), respectively. PXS-4787 hydrochloride reduces deposition and crosslinking of collagen I secreted by human fibroblasts .
    PXS-4787 hydrochloride
  • HY-124674A
    CCT365623 hydrochloride
    1 Publications Verification

    Monoamine Oxidase EGFR Akt TGF-beta/Smad Cancer
    CCT365623 hydrochloride is an orally active lysyl oxidase (LOX) inhibitor, with an IC50 of 0.89 μM. CCT365623 hydrochloride suppresses EGFR (pY1068) and AKT phosphorylation driven by EGF. CCT365623 hydrochloride is extremely well tolerated, and has good pharmacokinetic properties .
    CCT365623 hydrochloride
  • HY-114286

    Monoamine Oxidase Inflammation/Immunology
    PXS-5153A is a potent, selective, orally active and fast-acting lysyl oxidase like 2/3 enzymatic (LOXL2/LOXL3) inhibitor, with an IC50 of <40 nM for LOXL2 across all mammalian species and an IC50 of 63 nM for human LOXL3. PXS-5153A could reduce crosslinks and ameliorates fibrosis.
    PXS-5153A
  • HY-W010789

    H-Lys-Tyr-Lys-OH; Lys-Tyr-Lys

    Amino Acid Derivatives Others
    L-Lysyl-L-tyrosine-α-L-lysine is a lysine derivative .
    L-Lysyl-L-tyrosine-α-L-lysine
  • HY-114788A

    L-lysyl-L-cysteine TFA; Lys-Cys TFA; H-Lys-Cys-OH TFA

    Amino Acid Derivatives Others
    Lysylcysteine (L-Lysyl-L-cysteine) TFA is a dipeptide composed of lysine and cysteine .
    Lysylcysteine TFA
  • HY-151498

    Monoamine Oxidase Others
    PXS-4787 is a specific and effective pan-LOX (lysyl oxidase) inhibitor for abolishing lysyl oxidase activity. PXS-4787 inhibits LOX with IC50s of 2 μM (Bovine LOX), 3.2 μM (rh LOXL1), 0.6 μM (rh LOXL2), 1.4 μM (rh LOXL3), 0.2 μM (rh LOXL4), respectively .
    PXS-4787
  • HY-15782

    Aminoacyl-tRNA Synthetase Cancer
    YH16899 binds Lysyl-tRNA synthetase (KRS), and inhibits membrane translocation of KRS. YH16899 impares the interaction of KRS with 67LR. YH16899 inhibits tumor metastasis in mouse models .
    YH16899
  • HY-167811

    16:0 lysyl PG hydrochloride

    Biochemical Assay Reagents
    1,2-Dipalmitoyl-sn-glycero-3-[phospho-rac-(3-lysyl(1-glycerol))] hydrochloride (16:0 Lysyl PG hydrochloride) is a synthetic phospholipid with the activity of promoting the preparation of artificial vesicles.
    1,2-Dipalmitoyl-sn-glycero-3-[phospho-rac-(3-lysyl(1-glycerol))] hydrochloride
  • HY-138625B

    LOX-IN-3 dihydrochloride monohydrate

    Monoamine Oxidase Cardiovascular Disease Cancer
    PXS-5505 (LOX-IN-3 dihydrochloride monohydrate) (Compound 33) is an orally active lysyl oxidase (LOX) inhibitor. PXS-5505 can be used for fibrosis, cancer and angiogenesis research .
    PXS-5505
  • HY-168569

    Aminoacyl-tRNA Synthetase Infection
    DDD489 is a potent and selective Cryptosporidium lysyl-tRNA synthetase (CpKRS) inhibitor with IC50 values of 0.85 uM.DDD489 shows anti-cryptosporidials activity in vitro and in vivo .
    DDD489
  • HY-113770

    Lys-Thr

    Drug Intermediate Cancer
    Lysyl threonine (Lys-Thr) is a dipeptide. Lysyl threonine can be used to synthesize the pentapeptide Gly-Thr-Gly-Lys-Thr. Gly-Thr-Gly-Lys-Thr confers cell sensitivity to anticancer agents by inhibiting the binding of CAGE to GSK3β and reducing the expression of CyclinD1 .
    Lysyl threonine
  • HY-P3750

    Met-Lys-Bradykinin

    Bradykinin Receptor Cardiovascular Disease Endocrinology
    Methionyl-Lysyl-Bradykinin (Met-Lys-Bradykinin), a Bradykinin (HY-P0206) analogue, is a kinin .
    Methionyl-Lysyl-Bradykinin
  • HY-120791

    L-lysyl-L-lysine

    Drug Intermediate Others
    Lysyllysine (L-Lysyl-L-lysine) is a dipeptide composed of two L-lysine amino acids linked together. Lysyllysine is often used as an enzyme cleavage linker for connecting bioactive peptides, or as a component of more complex antibacterial agents .
    Lysyllysine
  • HY-W419440

    L-Leucine, L-lysyl-

    Biochemical Assay Reagents Others
    H-Lys-Leu-OH (L-Leucine, L-lysyl-) is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
    H-Lys-Leu-OH
  • HY-170573

    Monoamine Oxidase Cancer
    LOX-IN-5 (compound 22) is a selective and orally active lysyl oxidase-like 2 (LOXL2) inhibitor with an IC50 of <300 nM. LOX-IN-5 possess anti-fibrosis properties .
    LOXL2-IN-1
  • HY-Y1750R

    Reference Standards Monoamine Oxidase Endogenous Metabolite Metabolic Disease Cancer
    β-Aminopropionitrile (BAPN) is a specific, irreversible and orally active lysyl oxidase (LOX) inhibitor. β-Aminopropionitrile targets the active site of LOX or LOXL isoenzymes .
    β-Aminopropionitrile (Standard)
  • HY-149611

    Monoamine Oxidase Cancer
    Lysyl hydroxylase 2-IN-2 (compound 13) is a potent Lysyl hydroxylase 2 (LH2) inhibitor, with the IC50 of approximately 500 nM. Lysyl hydroxylase 2-IN-2 inhibits the migration in 344SQ WT cells, but not impedes the migration of the same cell line with an LH2 knockout cells .
    Lysyl hydroxylase 2-IN-2
  • HY-175503

    Bacterial Infection
    LysRS-IN-4 (Compound 49) is an orally active Mycobacterium tuberculosis LysRS (lysyl-tRNA synthetase) inhibitor. LysRS-IN-4 is promising for research of tuberculosis .
    LysRs-IN-4
  • HY-175304

    Parasite Infection
    DMU371 is a Trypanosoma cruzi lysyl-tRNA synthetase 1 (KRS1) inhibitor (IC50=185 nM). DMU371 is promising for research of infectious diseases .
    DMU371
  • HY-P991156

    Ras Inflammation/Immunology
    Rapaprutug is a monoclonal antibody targeting human KARS1 (lysyl-tRNA synthetase 1). Rapaprutug blocks the relevant inflammatory signaling pathways in which KARS1 is involved, reducing the production and release of inflammatory factors. Rapaprutug is promising for research of inflammatory diseases .
    Rapaprutug
  • HY-175305

    Parasite Infection
    DMU759 is a Lysyl-tRNA synthetase 1 (KRS1) inhibitor. DMU759 has potent anti-kinetoplastid activity against Trypanosoma cruzi , Trypanosoma brucei and Leishmania donovani. DMU759 significantly reduces parasitemia in acute Chagas disease mice model. DMU759 can be used for parasitic infection like Chagas disease research .
    DMU759
  • HY-107422A

    PAT-1251 hydrochloride; GB2064 hydrochloride

    Monoamine Oxidase Inflammation/Immunology
    PAT-1251 Hydrochloride is a potent, selective and oral lysyl oxidase-like 2 (LOXL2) inhibitor, with IC50s of 0.71 and 1.17 μM for hLOXL2 and hLOXL3, respectively, and also potently inhibits mouse, rat, and dog LOXL2 (IC50s, 0.10, 0.12, and 0.16 μM, respectively). PAT-1251 Hydrochloride is used in the research of fibrotic diseases.
    Lenumlostat hydrochloride
  • HY-165339

    TGF-β Receptor MMP Others
    Lysyl-phenylalanyl-lysine (Compound KFK) is a tripeptide and belongs to the peptide segments related to thrombospondin-1 (TSP-1) (HY-P0299). Lysyl-phenylalanyl-lysine can activate LAP-TGF-β1 and release active TGF-β1, thereby inhibiting abnormal expression of MMP. Lysyl-phenylalanyl-lysine can be used for research on skin aging-related diseases and poor wound healing .
    Lysyl-phenylalanyl-lysine
  • HY-165315

    TCMP-80

    Others Inflammation/Immunology
    Lysyl-serine (TCMP-80) is a T cell modulatory peptide with immunomodulatory properties .
    Lysyl-serine
  • HY-120791A

    L-lysyl-L-lysine trihydrochloride

    Drug Intermediate Others
    Lysyllysine (L-Lysyl-L-lysine) trihydrochloride is a dipeptide composed of two L-lysine amino acids linked together. Lysyllysine trihydrochloride is often used as an enzyme cleavage linker for connecting bioactive peptides, or as a component of more complex antibacterial agents .
    Lysyllysine trihydrochloride
  • HY-128401

    2-lysylcytidine

    Nucleoside Antimetabolite/Analog Drug Derivative Bacterial Others
    Lysidine (2-lysyl cytidine) is a lysine-containing Cytidine (HY-B0158) derivative. Lysidine can be found at the wobble position of bacterial AUA codon-specific tRNA Ile. This modification determines both codon and amino acid specificities of tRNA Ile .
    Lysidine
  • HY-D3208

    Fluorescent Dye Inflammation/Immunology
    oLOX is a fluorescent activity reporter. oLOX can be activated by lysyl oxidase family (LOXF) enzymes, which in turn releases a luciferin fluorescent product that reports LOXF enzyme activity. After oLOX is activated in in vitro fibrotic lung tissues, the fluorescence intensity increases, enabling real-time detection of fibrotic activity. oLOX can be used in studies related to pulmonary fibrosis .
    oLOX
  • HY-107422R

    PAT-1251 (Standard); GB2064 (Standard)

    Reference Standards Monoamine Oxidase Inflammation/Immunology
    Lenumlostat (Standard) is the analytical standard of Lenumlostat (HY-107422). This product is intended for research and analytical applications. PAT-1251 is a potent, selective and oral lysyl oxidase-like 2 (LOXL2) inhibitor, with IC50s of 0.71 and 1.17 μM for hLOXL2 and hLOXL3, respectively, and also potently inhibits mouse, rat, and dog LOXL2 (IC50s, 0.10, 0.12, and 0.16 μM, respectively); PAT-1251 is used in the research of fibrotic diseases .
    Lenumlostat (Standard)
  • HY-182388

    Others Inflammation/Immunology
    Cinflumide is an orally active muscle relaxant. Cinflumide shows antiinflammatory activity .
    Cinflumide
  • HY-180585

    Monoamine Oxidase Guanylate Cyclase PKG Collagen Cardiovascular Disease
    LOXL2/sGC modulator-2 (Compound 9k) is a selective and orally active lysyl oxidase-like 2 (LOXL2) and soluble guanylate cyclase (sGC) dual-target regulator. LOXL2/sGC modulator-2 shows inhibitory activity for LOXL2 with an IC50 of 0.1 μM and can activate sGC. LOXL2/sGC modulator-2 can ameliorate vascular remodeling and reduce pulmonary artery pressure. LOXL2/sGC modulator-2 can downregulate PKG1, PCNA, α-SMA, collagen I and fibronectin levels. LOXL2/sGC modulator-2 can be used for the research of pulmonary arterial hypertension .
    LOXL2/sGC modulator-2

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: